Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104550914 | 10455091 | 4 | F | 2014 | 20140929 | 20140916 | 20160719 | EXP | BR-AMGEN-BRASP2014067062 | AMGEN | 44.00 | YR | A | F | Y | 62.00000 | KG | 20160718 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 104550914 | 10455091 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, ONCE WEEKLY | N | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 104550914 | 10455091 | 2 | C | LYRICA | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 104550914 | 10455091 | 3 | C | LYRICA | PREGABALIN | 1 | 75 MG, UNK | 0 | 75 | MG | |||||||||
| 104550914 | 10455091 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | 0 | |||||||||||
| 104550914 | 10455091 | 5 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | 0 | |||||||||||
| 104550914 | 10455091 | 6 | C | ADDERA D3 | CHOLECALCIFEROL | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 104550914 | 10455091 | 7 | C | ALPRAZOLAN | ALPRAZOLAM | 1 | 1 MG, UNK | 0 | 1 | MG | |||||||||
| 104550914 | 10455091 | 8 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 104550914 | 10455091 | 9 | C | VENLAFAXINE HYDROCHLORIDE. | VENLAFAXINE HYDROCHLORIDE | 1 | 37.5 MG, UNK | 0 | 37.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 104550914 | 10455091 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 104550914 | 10455091 | OT |
| 104550914 | 10455091 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 104550914 | 10455091 | Abdominal pain | |
| 104550914 | 10455091 | Back pain | |
| 104550914 | 10455091 | Cholelithiasis | |
| 104550914 | 10455091 | Dyspnoea | |
| 104550914 | 10455091 | Gastritis | |
| 104550914 | 10455091 | Headache | |
| 104550914 | 10455091 | Hypersensitivity | |
| 104550914 | 10455091 | Influenza | |
| 104550914 | 10455091 | Injection site erythema | |
| 104550914 | 10455091 | Injection site pain | |
| 104550914 | 10455091 | Nephrolithiasis | |
| 104550914 | 10455091 | Oropharyngeal pain | |
| 104550914 | 10455091 | Osteoarthritis | |
| 104550914 | 10455091 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 104550914 | 10455091 | 1 | 20140811 | 0 |